CASR and hypercalcemia disease: Both unaffected and heterozygous fetuses (with 1 inactivating mutation of the CaSR gene) are at risk for transient or permanent hypoparathyroidism due to suppression of their parathyroid glands in the setting of maternal hypercalcemia in pregnancy [4].